| Assets |
|
|
|
|
|
|
|
|
|
| Holding company cash and investments (including assets pledged for derivative obligations – $79.5; December 31, 2019 – $5.5) |
|
|
|
|
|
|
|
|
|
| Holding company cash and investments |
|
|
|
|
|
|
|
|
|
| Portfolio investments |
|
|
|
|
|
|
|
|
|
| Total holding company cash and investments (including assets pledged for derivative obligations – $79.5; December 31, 2019 – $5.5) |
|
|
|
|
|
|
|
|
|
| Holding company cash and investments (including assets pledged for derivative obligations - $207.8; December 31, 2024 - $193.6) |
|
|
|
|
|
|
|
|
|
| Insurance contract receivables |
|
|
|
|
|
|
|
|
|
| Portfolio investments |
|
|
|
|
|
|
|
|
|
| Subsidiary cash and short term investments (including restricted cash and cash equivalents - $1,246.4;December 31, 2020 - $751.9) |
|
|
|
|
|
|
|
|
|
| Holding company cash and investments |
|
|
|
|
|
|
|
|
|
| Portfolio investments |
|
|
|
|
|
|
|
|
|
| Total subsidiary cash and short term investments (including restricted cash and cash equivalents - $1,246.4;December 31, 2020 - $751.9) |
|
|
|
|
|
|
|
|
|
|
|
|
| Bonds (cost $13,836.3; December 31, 2020 - $14,916.1) |
|
|
|
|
|
|
|
|
|
| Preferred stocks (cost $576.6; December 31, 2020 - $268.3) |
|
|
|
|
|
|
|
|
|
| Common stocks (cost $4,717.2; December 31, 2020 - $4,635.5) |
|
|
|
|
|
|
|
|
|
| Investments in associates (fair value $5,671.9; December 31, 2020 - $4,154.3) |
|
|
|
|
|
|
|
|
|
| Portfolio investments |
|
|
|
|
|
|
|
|
|
| Total investments in associates (fair value $5,671.9; December 31, 2020 - $4,154.3) |
|
|
|
|
|
|
|
|
|
| Investment in associate held for sale (fair value nil; December 31, 2020 - $729.5) |
|
|
|
|
|
|
|
|
|
| Subsidiary cash and short term investments (including restricted cash and cash equivalents - $640.4; December 31, 2024 - $1,240.7) |
|
|
|
|
|
|
|
|
|
| Bonds (cost $39,655.2; December 31, 2024 - $37,852.9) |
|
|
|
|
|
|
|
|
|
| Preferred stocks (cost $957.4; December 31, 2024 - $944.6) |
|
|
|
|
|
|
|
|
|
| Common stocks (cost $7,926.0; December 31, 2024 - $7,116.1) |
|
|
|
|
|
|
|
|
|
| Investments in associates (fair value $11,057.7; December 31, 2024 - $8,144.8) |
|
|
|
|
|
|
|
|
|
| Derivatives and other invested assets (cost $1,312.7; December 31, 2024 - $903.9) |
|
|
|
|
|
|
|
|
|
| Portfolio investments |
|
|
|
|
|
|
|
|
|
| Total derivatives and other invested assets (cost $1,312.7; December 31, 2024 - $903.9) |
|
|
|
|
|
|
|
|
|
|
|
|
| Assets pledged for derivative obligations (cost $119.6; December 31, 2020 - $196.1) |
|
|
|
|
|
|
|
|
|
| Holding company cash and investments |
|
|
|
|
|
|
|
|
|
| Portfolio investments |
|
|
|
|
|
|
|
|
|
| Assets pledged for derivative obligations (cost $187.2; December 31, 2024 - $154.8) |
|
|
|
|
|
|
|
|
|
| Fairfax India cash, portfolio investments and associates (fair value $3,685.1; December 31, 2024 - $3,163.3) |
|
|
|
|
|
|
|
|
|
| Portfolio investments |
|
|
|
|
|
|
|
|
|
| Total portfolio investments |
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred premium acquisition costs |
|
|
|
|
|
|
|
|
|
| Recoverable from reinsurers (including recoverables on paid losses - $1,454.2; December 31, 2021 - $884.3) |
|
|
|
|
|
|
|
|
|
| Assets held for sale |
|
|
|
|
|
|
|
|
|
| Reinsurance contract assets held |
|
|
|
|
|
|
|
|
|
| Deferred income tax assets |
|
|
|
|
|
|
|
|
|
| Goodwill and intangible assets |
|
|
|
|
|
|
|
|
|
| Other assets |
|
|
|
|
|
|
|
|
|
| Non-insurance companies |
|
|
|
|
|
|
|
|
|
| Total other assets |
|
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
|
|
|
|
|
|
|
|
|
|
|
|
| Liabilities |
|
|
|
|
|
|
|
|
|
| Accounts payable and accrued liabilities |
|
|
|
|
|
|
|
|
|
| Non-insurance companies |
|
|
|
|
|
|
|
|
|
| Total accounts payable and accrued liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
| Income taxes payable |
|
|
|
|
|
|
|
|
|
| Non-insurance companies |
|
|
|
|
|
|
|
|
|
| Total income taxes payable |
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative obligations |
|
|
|
|
|
|
|
|
|
| Holding company cash and investments |
|
|
|
|
|
|
|
|
|
| Total derivative obligations |
|
|
|
|
|
|
|
|
|
|
|
|
| Funds withheld payable to reinsurers |
|
|
|
|
|
|
|
|
|
| Liabilities associated with assets held for sale |
|
|
|
|
|
|
|
|
|
| Deferred income tax liabilities |
|
|
|
|
|
|
|
|
|
| Insurance contract payables |
|
|
|
|
|
|
|
|
|
| Insurance contract liabilities |
|
|
|
|
|
|
|
|
|
| Borrowings |
|
|
|
|
|
|
|
|
|
| Holding company cash and investments |
|
|
|
|
|
|
|
|
|
| Holding company, insurance, and reinsurance companies |
|
|
|
|
|
|
|
|
|
| Holding company and insurance and reinsurance companies |
|
|
|
|
|
|
|
|
|
| Non-insurance companies |
|
|
|
|
|
|
|
|
|
| Total borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
| Total liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
| Equity |
|
|
|
|
|
|
|
|
|
| Equity in stock |
|
|
|
|
|
|
|
|
|
| Common shares |
|
|
|
|
|
|
|
|
|
| Preferred shares |
|
|
|
|
|
|
|
|
|
| Shareholders' equity attributable to shareholders of Fairfax |
|
|
|
|
|
|
|
|
|
| Non-controlling interests |
|
|
|
|
|
|
|
|
|
| Non-insurance companies |
|
|
|
|
|
|
|
|
|
| Total non-controlling interests |
|
|
|
|
|
|
|
|
|
|
|
|
| Total equity |
|
|
|
|
|
|
|
|
|
| Total liabilities and total equity |
|
|
|
|
|
|
|
|
|
